Introduction of biosimilar insulins in Europe.

about

Introduction of biosimilar insulins in Europe.

Item

http://www.wikidata.org/entity/Q39368850

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Introduction of biosimilar insulins in Europe.

@en

Introduction of biosimilar insulins in Europe.

@nl

type

Item

label

Introduction of biosimilar insulins in Europe.

@en

Introduction of biosimilar insulins in Europe.

@nl

prefLabel

Introduction of biosimilar insulins in Europe.

@en

Introduction of biosimilar insulins in Europe.

@nl

P1476

Introduction of biosimilar insulins in Europe.

@en

P2093

C Mathieu

http://www.w3.org/2001/XMLSchema#string

D Dahl

http://www.w3.org/2001/XMLSchema#string

J Kiljanski

http://www.w3.org/2001/XMLSchema#string

T Heise

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

The emergence of biosimilar insulin preparations--a cause for concern?

A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia

Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.

Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR).

Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus.

Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus.

P304

1340-1353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1111/DME.13400

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Melanie J Davies

P5008

ScienceSource

P577

2017-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28608570

http://www.w3.org/2001/XMLSchema#string

P921

Chidenhi

Asikyire yadee

peptide

P932

5637898

http://www.w3.org/2001/XMLSchema#string